Literature DB >> 12162517

Unilateral neuroretinitis and periparillary serous retinal detachment in cat-scratch disease.

A Osman Saatci1, F Hakan Oner, Aydanur Kargi, Salih Kavukcu.   

Abstract

Cat-scratch disease is a self-limited infection characterized by subacute regional lymphadenitis, which is usually preceded by a history of being scratched by a cat infected with the Bartonella species. Neuroretinitis, retinochoroiditis, isolated papillitis and peripapillary angiomatosis are features of posterior segment involvement. However, vision loss is very rare. We report a patient with cat-scratch disease associated with unilateral neuroretinitis and peripapillary serous retinal detachment, and discuss its fluorescein and indocyanine green angiographic features.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162517     DOI: 10.3341/kjo.2002.16.1.43

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  4 in total

1.  Bartonella henselae- and quintana-associated uveitis: a case series and approach of a potentially severe disease with a broad spectrum of ocular manifestations.

Authors:  Dimitrios Kalogeropoulos; Ioannis Asproudis; Maria Stefaniotou; Marilita M Moschos; Andreas Mentis; Konstantinos Malamos; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2019-03-09       Impact factor: 2.031

Review 2.  Posterior Segment Manifestations of Cat-scratch Disease: A Mini-review of the Clinical and Multi-modal Imaging Features.

Authors:  Omer Karti; Ferdane Ataş; Ali Osman Saatci
Journal:  Neuroophthalmology       Date:  2021-06-11

3.  Diverse Clinical Signs of Ocular Involvement in Cat Scratch Disease.

Authors:  Merih Oray; Sumru Önal; Aylin Koç Akbay; İlknur Tuğal Tutkun
Journal:  Turk J Ophthalmol       Date:  2017-01-17

4.  Bilateral neuroretinits and exudative retinal detachment with multifocal subretinal deposits secondary to Bartonella henselae infection.

Authors:  Efrat Fleissig; Fiona Kim; Douglas Kenneth Sigford; Charles C Barr
Journal:  Am J Ophthalmol Case Rep       Date:  2021-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.